V

Verrica Pharmaceuticals
D

VRCA

6.31000
USD
-0.31
(-4.68%)
Market Closed
Volume
27,064
EPS
0
Div Yield
0
P/E
-0
Market Cap
34,100,708
News

Title: Verrica Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.